29 related articles for article (PubMed ID: 23169385)
1. Lupus syndrome, hypothyroidism and bullous skin lesions after interferon alfa therapy for hepatitis C in a haemodialysis patient.
Pouthier D; Theissen F; Humbel RL
Nephrol Dial Transplant; 2002 Jan; 17(1):174. PubMed ID: 11773492
[No Abstract] [Full Text] [Related]
2. Editorial: HBsAg seroclearance after pegylated interferon treatment-The beginning of the end.
Mak LY
Aliment Pharmacol Ther; 2023 Nov; 58(10):1103-1104. PubMed ID: 37885169
[No Abstract] [Full Text] [Related]
3. Editorial: HBsAg seroclearance after pegylated interferon treatment-The beginning of the end. Authors' reply.
Gao N; Guan G; Zhao Q; Gao Z
Aliment Pharmacol Ther; 2023 Nov; 58(10):1105-1106. PubMed ID: 37885165
[No Abstract] [Full Text] [Related]
4. Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients.
Teta D; Lüscher BL; Gonvers JJ; Francioli P; Phan O; Burnier M
Nephrol Dial Transplant; 2005 May; 20(5):991-3. PubMed ID: 15741205
[No Abstract] [Full Text] [Related]
5. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
Quinn D; Kuchler E; Deming P; Arora S
Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752
[No Abstract] [Full Text] [Related]
6. [Secondary hemophagocytic syndrome due to Peg-interferon administration].
Ruiz Ramos J
Farm Hosp; 2014 Jan; 38(1):73-4. PubMed ID: 24483865
[No Abstract] [Full Text] [Related]
7. Severe renal impairment during triple therapy with telaprevir.
Carrier P; Chambaraud T; Vong C; Guillaudeau A; Debette-Gratien M; Jacques J; Legros R; Sautereau D; Essig M; Loustaud-Ratti V
Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):e69-71. PubMed ID: 24461554
[No Abstract] [Full Text] [Related]
8. A rare complication of pegylated interferon Alfa 2a in a hepatitis C-positive patient on maintenance hemodialysis.
Satish R; ; Mathew T
Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):139-42. PubMed ID: 22237239
[No Abstract] [Full Text] [Related]
9. Peripheral nervous system involvement in a haemodialysis patient treated with pegylated interferon.
Ruiz-Fuentes MC; Rubert-Gómez De Quero A; De Gracia-Guindo C; Galindo-Sacristán P; Osuna-Ortega A
Nefrologia; 2012; 32(6):863-5. PubMed ID: 23169385
[No Abstract] [Full Text] [Related]
10. [Sarcoidosis associated with the treatment of hepatitis C: case report and Spanish literature review].
Trullàs JC; Hernández-Marcet P; Bisbe J
Med Clin (Barc); 2011 May; 136(14):649-50. PubMed ID: 21051060
[No Abstract] [Full Text] [Related]
11. "Hepatitis C (HCV) treatment is not a "one size fits all".
Bukeirat FA; Bukeirat MM
W V Med J; 2012; 108(2):20, 22-4. PubMed ID: 22655431
[TBL] [Abstract][Full Text] [Related]
12. Peginterferon- and ribavirin-induced bipolar episode successfully treated with lamotrigine without discontinuation of antiviral therapy.
Navinés R; Castellví P; Solà R; Martín-Santos R
Gen Hosp Psychiatry; 2008; 30(4):387-9. PubMed ID: 18585548
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
